Survey and comparative study to Evaluate the efficacy of Ayurvedic formulation and Shirodhara in Attention Deficit Hyperactivity Disorder.

Phase 2

Not yet recruiting

• Conditions: ADHD(Attention Deficit Hyperactivity Disorder)

• Registration Number: CTRI/2018/05/014001
• Lead Sponsor: Dr Rakesh Kumar Nagar

Brief Summary

**Attention deficit hyperactivity disorder (ADHD)** is a mental disorder of the neurodevelopmental type. The core symptoms of ADHD are inattention, hyperactivity, and impulsivity. It is one of the most common and most extensively studied behavioral disorders in school age children. Genetic, epigenetic, and environmental factors interact to give rise to the ADHD phenotypes.Biological and psychosocial factors also contribute to ADHD.  Prenatal exposure to alcohol, cocaine, and nicotine are associated with ADHD phenotypes.

Studies of prevalence of ADHD across the globe have generally reported that 9% of school age children are affected, may result of differing sampling and testing techniques. ADHD is highly prevalent in children worldwide and prevalence in adults is increasingly recognized.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2018-05-18
• Study Start: 2018-05-28

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• 1)School children aged between 6 to 12 years.
• 2)Having sign and symptoms for ADHD.
• 3)Children with average/normal IQ.

Exclusion Criteria

• 1)Children with known physical disability ( deafness or visual problems) 2)Children with psychiatric disorders.
• 3)Children with gross brain damage causing mental retardation.
• 4)Children with any genetic disorder 5) Children with •Epilepsy •on chronic medication(e.g. steroids) •previous history of an infectious disease involving central nervous system (e.g. encephalitis) •intellectual disability •autism 6) Unreliable history.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1)To study the prevalence of ADHD in school children (6-12 years) in Jaipur, Rajasthan.	3 months
2)To study the gender difference in prevalence of ADHD.	3 months
3)To assess the efficacy of tab. Eleva and Shirodhara in Attention Deficit Hyperactivity Disorder.	3 months

Secondary Outcome Measures

Name	Time	Method
To provide relief in the symptoms of ADHD	3 Months

Trial Locations

Locations (1)

national institute of ayurveda jaipur; 🇮🇳 Jaipur, RAJASTHAN, India

national institute of ayurveda jaipur

🇮🇳Jaipur, RAJASTHAN, India

Dr Rakesh Kumar Nagar

Principal investigator

9414062099

drrknagar@gmail.com